Although senescence has its unfavorable effects, it has been shown that some currently used anticancer therapies, such as radiation therapy or PKC activator ingenol‐3‐angelate (ingenol mebutate), drive the cancer cells to senescence and this therapy‐induced senescence is considered as one strategy for cancer therapy 28, 29, 30. This evidence concerns the gene PRRT2 and cancer.